4 Drugmakers Who Beat Q3 Estimates Tuesday

By | October 27, 2015

Scalper1 News

The battered drug industry got a blast of good news Tuesday morning as three big pharmas and one sizable biotech beat Wall Street’s Q3 expectations, sending their stocks up. United Therapeutics (UTHR) was up 11% in midday trading on the stock market today after it reported revenue of $386.2 million, up 17% from the year-earlier quarter and beating analysts’ consensus by more than $22 million, according to Thomson Reuters. Earnings excluding Scalper1 News

Scalper1 News